Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The American Journal of Medicine
- Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study.J Am Coll Cardiol. 2020; 76: 2982-3021
- Role of acute infection in triggering acute coronary syndromes.Lancet Infect Dis. 2010; 10: 83-92
World Health Organization (WHO). Global influenza strategy 2019-2030. Available at: https://apps.who.int/iris/handle/10665/311184. Accessed October 5, 2022.
- Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome.Eur Heart J. 2011; 32: 1730-1735
- The efficacy of influenza vaccination in reducing cardiovascular events in patients with coronary artery diseases: IVCAD study.Clin Microbiol Infect. 2009; 15: S395-S396
- Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study.Eur Heart J. 2008; 29: 1350-1358
- Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study.Eur Heart J. 2004; 25: 25-31
- Influenza vaccination after myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial.Circulation. 2021; 144: 1476-1484
- Influenza vaccination for cardiovascular prevention: further insights from the IAMI trial and an updated meta-analysis.Curr Cardiol Rep. 2022; 24: 1327-1335
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.BMJ. 2021; 372: n71
- Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.JAMA. 2013; 310: 1711-1720
- Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology.J Am Coll Cardiol. 2006; 48: 1498-1502
- 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.Eur Heart J. 2021; 42: 1289-1367
- Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial.Eur Heart J. 2022; 43: 4378-4388
- The impact of influenza vaccination in patients with cardiovascular disease: an overview of systematic reviews.Trends Cardiovasc Med. 2021; 31: 315-320
- Role of endothelial dysfunction in coronary artery disease and implications for therapy.Am J Cardiol. 1997; 80: 11I-16I
- Vascular events responsible for thrombotic occlusion of a blood vessel.Clin Cardiol. 1993; 16: 761-762
- Influenza and coronary artery disease: exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in prevention of myocardial infarction.Rev Cardiovasc Med. 2014; 15: 168-175
- The link between influenza and myocardial infarction: vaccination protects.Eur Heart J Suppl. 2022; 24: I84-I88
- Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice.Circulation. 2003; 107: 762-768
Centers for Disease Control and Prevention (CDC). FluVaxView: Influenza (Flu): Influenza vaccination coverage for persons 6 months and older. Available at: https://www.cdc.gov/flu/fluvaxview/interactive-general-population.htm. Accessed October 9, 2022.
European Centre for Disease Prevention and Control (ECDC). Seasonal influenza vaccination and antiviral use in EU/EEA Member States: Overview of vaccine recommendations for 2017-2018 and vaccination coverage rates for 2015-2016 and 2016-2017 influenza seasons. Available at:https://www.ecdc.europa.eu/sites/default/files/documents/Seasonal-influenza-antiviral-use-EU-EEA-Member-States-December-2018_0.pdf. Accessed February 20, 2023.
- Efficacy and safety of COVID-19 vaccines: a network meta-analysis.J Evid Based Med. 2022; 15: 245-262
Publication stageIn Press Journal Pre-Proof
Conflicts of Interest: None.
Authorship: All authors had access to the data and a role in writing the manuscript.